Skip to main content
JUPITER NEUROSCIENCES, INC. logo

JUPITER NEUROSCIENCES, INC. — Investor Relations & Filings

Ticker · JUNS ISIN · US48208B2034 US Manufacturing
Filings indexed 144 across all filing types
Latest filing 2025-11-20 Regulatory Filings
Country US United States of America
Listing US JUNS

About JUPITER NEUROSCIENCES, INC.

https://jupiterneurosciences.com/

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on developing treatments for neuroinflammation, central nervous system (CNS) disorders, and rare diseases. The company's core technology is a unique resveratrol-based platform. Its flagship product candidate, JOTROL™, is an oral formulation of resveratrol designed to address neuroinflammation and oxidative stress. The therapeutic pipeline targets a range of conditions, including neurodegenerative and rare diseases, aiming to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
8-K/A
Regulatory Filings
2025-11-20 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-14 English
DEFA14A
Regulatory Filings
2025-11-07 English
ARS
Annual Report
2025-11-06 English
DEFA14A
Regulatory Filings
2025-11-06 English
DEF 14A
Proxy Solicitation & Information Statement
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.